TREM2 and neoplasm: On the other hand, another independent study showed that use of anti-TREM2 monoclonal antibody modulated and suppressed the tumor-associated macrophage population and also led to the infiltration of CD8+ tumor associated lymphocytes in tumor microenvironment [142].